Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects

Drug and Alcohol Dependence

Volumn 82, Issue 3, 2006, Pages 218-223

  Pud, Dorit ^a,b   Cohen, Doron ^c   Lawental, Eli ^c   Eisenberg, Elon ^b,d,e  

^a UNIVERSITY OF HAIFA   (Israel)

^b Haifa Medical Center Rothschild   (Israel)

^c Haifa Drug Abuse Treatment Center   (Israel)

^d RAMBAM MEDICAL CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cold pressor test; Heroin; Human; Methadone; Rehabilitation; Withdrawal

Indexed keywords

DIAMORPHINE; METHADONE; OPIATE;

ADULT; ARTICLE; COLD PRESSOR TEST; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG MISUSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERALGESIA; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NOCICEPTION; OPIATE ADDICTION; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; REACTION TIME; SAMPLE SIZE; URINALYSIS; VISUAL ANALOG SCALE; WITHDRAWAL REFLEX;

CHRONIC DISEASE; FEMALE; HUMANS; ISRAEL; MALE; OPIOID-RELATED DISORDERS; PAIN; PERCEPTION; REACTION TIME; REFERENCE VALUES; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 33645789099     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.09.007     Document Type: Article

References (37)

1. Alterman I.A., O'Brien P.C., and McLellan A.T. Differential therapeutics for substance abuse. In: Frances J.R., and Miller I.S. (Eds). Clinical Textbook of Addictive Disorders (1991), The Guilford Press, New York
2. Beck T.A., Wright D.F., Newman F.C., and Liese S.B. Cognitive Therapy of Substance Abuse (1993), The Guilford Press, New York
3. Celerier E., Laulin J.P., Corcuff J.B., Le Moal M., and Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J. Neurosci. 21 (2001) 4074-4080
4. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., and Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
5. Chen A.C.N., Dworkin S.F., Haug J., and Gehrig J. Human pain responsivity in a tonic pain model: psychological determinants. Pain 37 (1989) 143-160
6. Chia Y.Y., Liu K., Wang J.J., Kuo M.C., and Ho S.T. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can. J. Anaesth. 46 (1999) 872-877
7. Cleeland C.S., Nakamura Y., Howland E.W., Morgan N.R., Edwards K.R., and Backonja M. Effects of oral morphine on cold pressor tolerance time and neuropsychological performance. Neuropsychopharmacology 15 (1996) 252-262
8. Compton P., Athanasos P., and Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. Pain 4 (2003) 511-519
9. Compton P., Charuvastra V.C., and Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend. 63 (2001) 139-146
10. Compton M.A. Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. Pain Symptom Manage. 9 (1994) 462-473
11. Cooper D.W., Lindsay S.L., Ryall D.M., Kokri M.S., Eldabe S.S., and Lear G.A. Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine?. Br. J. Anaesth. 78 (1997) 311-313
12. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., and Ling W. Hyperalgesic responses in methadone maintenance patients. Pain 90 (2001) 91-96
13. Doverty M., Somogyi A.A., White J.M., Bochner F., Beare C.H., Menelaou A., and Ling W. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 93 (2001) 155-163
14. Fillingim R.B. Sex, gender, and pain: women and men really are different. Curr. Rev. Pain 4 (2000) 24-30
15. Grath M., Massalha W., Pud D., Adler R., and Eisenberg E. Can co-administration of oxycodone and morphine produce antinociceptive synergy in humans? Results of an experimental model of cold-induced pain. Br. J. Clin. Pharmacol. 58 (2004) 235-242
16. Guignard B., Bossard A.E., Coste C., Sessler D.I., Lebrault C., Alfonsi P., Fletcher D., and Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93 (2000) 409-417
17. Harris G., and Rollman G.B. The validity of experimental pain measures. Pain 17 (1983) 369-376
18. Hay J.L., White J.M., Somogyi A.A., Bochner F., Rounsefell B., and Semple T. Clinical evidence for opioid-induced hyperalgesia. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, vol. 10 (2003) 4
19. Ho A., and Dole V.P. Pain perception in drug-free and in methadone-maintained human ex-addicts. Proc. Soc. Exp. Biol. Med. 162 (1979) 392-395
20. Khantzian E.J. The self-medication hypothesis of addictive disorders. Am. J. Psychiatry 142 (1985) 1259-1264
21. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Rev. Psychiatry 4 (1997) 231-244
22. Koppert W., Sittl R., Scheuber K., Alsheimer M., Schmelz M., and Schuttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 99 (2003) 152-159
23. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., and Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94 (2002) 1263-1269
24. Lawental E., and Ya'akobi Z. Is initial methadone treatment influencing detoxification in thirty days inpatient programs?. Soc. Welfare J. 17 (1997) 441-448
25. Levinson D. Detoxification in three methods a one year follow-up study. Soc. Welfare J. 18 (1998) 141-159
26. Luginbuhl M., Gerber A., Schnider T.W., Petersen-Felix S., Arendt-Nielsen L., and Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth. Analg. 96 (2003) 726-732
27. Mao J., Price D.D., and Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14 (1994) 2301-2312
28. Mao J., Sung B., Ji R.R., and Lim G. Chronic morphine induces down regulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22 (2002) 8312-8323
29. Martin J.E., and Inglis J. Pain tolerance and addiction. Br. J. Soc. Clin. Psychol. 4 (1965) 224-229
30. Martin W.R., Jasinski D.R., Haertzen C.A., Kay D.C., Jones B.E., Mansky P.A., and Carpenter R.W. Methadone - a reevaluation. Arch. Gen. Psychiatry 28 (1973) 286-295
31. Reznikov I., Pud D., and Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic non-malignant pain. Br. J. Clin. Pharmacol. 60 (2005) 311-318
32. White J.M. Pleasure into pain: the consequences of long-term opioid use. Addict. Behav. 29 (2004) 1311-1324
33. Wiesenfeld-Hallin Z., and Duranti R. Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat. Peptides 8 (1987) 153-158
34. Wiesenfeld-Hallin Z., Xu X.J., Hakanson R., Feng D.M., and Folkers K. Low-dose intrathecal morphine facilitates the spinal flexor reflex by releasing different neuropeptides in rats with intact and sectioned peripheral nerves. Brain Res. 551 (1991) 157-162
35. Wolff B.B. Methods of testing pain mechanisms in normal man. In: Wall P.D., and Melzack R. (Eds). Textbook of Pain. 2nd ed (1984), Churchill Livingstone, Edinburgh 186-194
36. Woolf C.J. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res. 209 (1981) 491-495
37. Xu X.J., Colpaert F., and Wiesenfeld-Hallin Z. Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance. Trends Pharmacol. Sci. 24 (2003) 634-639